Experimental and Clinical Endocrinology and Diabetes
Journal metrics
Annual Clarivate and SCImago indicators.
| Year | JCR | SJR | ||||
|---|---|---|---|---|---|---|
| IF | IF quartile | Rank (percentile) | SJR | SJR quartile | Rank (percentile) | |
| 2025 | 1.8 | Q4 | 20.5% | 0.529 | Q2 | 63.0% |
| 2024 | 1.7 | Q4 | 21.2% | 0.553 | Q2 | 65.7% |
| 2023 | 1.6 | Q4 | 24.6% | 0.493 | Q2 | 64.5% |
| 2022 | 1.8 | Q4 | 22.2% | 0.586 | Q2 | 71.3% |
| 2021 | 2.4 | Q4 | 37.7% | 0.577 | Q2 | 71.6% |
| 2020 | — | — | 0.632 | Q2 | 73.2% | |
| 2019 | — | — | 0.567 | Q2 | 71.0% | |
| 2018 | — | — | 0.667 | Q2 | 73.7% | |
Impact history
Annual SJR and Impact Factor trend.
SJRIF
Journal record
eISSN
1439-3646
ISSN
0947-7349
country
DEcoverage
1983-2026